EUVIMED · CrossrefZeitschrift
The Open Prostate Cancer Journal
ISSN 1876-8229 · Bentham Science Publishers Ltd.
Neueste Artikel
Assessing Expression of MUC1 and ZAG Protein Biomarkers in Prostate Biopsies Improves Prediction of Adverse Pathology Following Radical Prostatectomy
Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer
The Impact of Tumor Volume on Outcomes after Radical Prostatectomy: Implications for Prostate Cancer Screening
The Impact of Tumor Volume on Outcomes after Radical Prostatectomy: Implications for Prostate Cancer Screening
The Use of IIEF-5 for Reporting Erectile Dysfunction Following Nerve-Sparing Radical Retropubic Prostatectomy
Does Body Mass Index Influence the Outcomes After Surgery for Locally Advanced Prostate Cancer?
Prostate Cancer Lymph Node Metastasis
Racial Differences in 3-D Nuclear Chromatin Patterns of Prostate Cancer
Overexpression of TP53 is Associated with Aggressive Prostate Cancer but does not Distinguish Disease in BRCA1 or BRCA2 Mutation Carriers from a Control Group
Stereological Estimate of the Length of Microvessels and the Number, Proliferation and Apoptosis of Endothelial Cells in Prostate Cancer
Strontium 89 Combined with Gemcitabine in Androgen-Resistant Prostate Cancer: Results of a Phase I-II Study
Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer
Prostasome Involvement in the Development and Growth of Prostate Cancer~!2009-07-10~!2009-12-09~!2010-02-11~!
Hot Topic: [Androgen deprivation in Localized Prostate cancer: Indications, Types and Side effects (Guest Editor: May Abdel-Wahab)]
Role of Androgen Deprivation in Patients Undergoing Radical Prostatectomy
The Use of Androgen Deprivation in Conjunction with Radiation in Localized Prostate Cancer
Androgen Deprivation in Prostate Cancer Patients Treated with Brachytherapy
Side Effects and Complications of Androgen Deprivation in Prostate Cancer Patients
Current Medical and Surgical Options for Androgen Deprivation in Prostate Cancer Patients
The Mechanism of Androgen Deprivation and the Androgen Receptor
Cell-Free DNA: A Novel Biomarker for Patients with Prostate Cancer?
ERG Rearrangement as a Clonal Expansion Marker for Prostate Cancer
Prostate Cancer Vaccines, Fibrin and Selenium: A Conceptual Review~!2010-05-31~!2010-06-16~!2010-08-07~!
AMACR Detection in Urine Samples. Lack of Clinical Application in Routine Practice~!2010-02-11~!2010-06-23~!2010-08-26~!
Gene Expression Changes Induced by Genistein in the Prostate Cancer Cell Line LNCaP
Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer
Editorial: Androgen Deprivation in Localized Prostate Cancer: Indications, Types and Side Effects
Role of Androgen Deprivation in Patients Undergoing Radical Prostatectomy~!2009-09-25~!2009-12-19~!2010-04-23~!
The Use of Androgen Deprivation in Conjunction with Radiation in Localized Prostate Cancer~!2009-08-29~!2009-12-19~!2010-04-23~!
Androgen Deprivation in Prostate Cancer Patients Treated with Brachytherapy~!2009-10-12~!2009-12-19~!2010-04-23~!
EUVIMED